Regeneron (REGN)
$927.89 +13.33% Close Oct 30, 2026 Live
Regeneron stock today
Regeneron closed at $927.89 on October 30, 2026, up 13.33% on the day. Over the past year it returned +42.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $97.3 billion.
$600.00$700.00$800.00$900.00
NovJan 2026MarMayJulSep
| Period | REGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +22.4% | -0.9% |
| 3 months | +25.8% | +2.1% |
| Year to date | +20.7% | +11.7% |
| 1 year | +42.6% | +12.4% |
| 3 years | +20.4% | +88.5% |
| 5 years | +46.3% | +76.0% |
Key statistics
- Market value
- $97.3B
- P/E (trailing)
- 23.0
- Forward P/E
- 17.2
- Price / sales
- 6.3
- Dividend yield
- 0.40%
- 52-week range
- $600.66 to $927.89
About Regeneron
Discovers, develops, and manufactures monoclonal antibody and other biologics for various diseases.
Sector: Health Care · Industry: Biotechnology
More on Regeneron
- Financials: revenue, earnings and segmentsRevenue +1% in the year to Dec 2025
- Valuation: P/E history and peersP/E 23.0, median 18.7 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $2,632 today
No forecast, no recommendation. This page describes Regeneron from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.